The Potential of Peroxisome Proliferator-Activated Receptor &ggr; (PPAR&ggr;) Ligands in the Treatment of Hematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|7|9|877-887

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.9, 2007-09, pp. : 877-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

By Fenner Martin H   Elstner Elena  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 557-568

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPAR) and its Lipid Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2803-2821

Bentham Science Publishers

Access to resources Recommend Favorite